A Japan-based pharmaceutical development company utilized Signant's eCOA solutions and knowledge to ensure the reliability of endpoints in their Phase 3 and extended-duration CNS trials.

This comprehensive overview highlights the critical role these platforms play in modern clinical research, emphasizing their impact on data integrity and trial efficiency.

Discover how eCOA use drove >90% adherence across an extensive weight management master protocol clinical trial with multiple sub-studies across 70+ research sites.

<p>While the digital transformation of clinical trials has made tremendous strides in recent years, the plethora of new technologies can overwhelm. Learn how to help sites and sponsors combat the overload of technology.</p>

Clinical trials are essential to advancing medicine, yet they carry significant environmental costs. Inefficiencies not only drive emissions but also risk drug shortages and trial delays, and clinical technology solutions offer a pathway to more sustainable research.

A site-focused strategy drove strong eConsent adoption in a complex women’s health study, showing how tailored training and hands-on support boost engagement and compliance.

This comprehensive overview highlights the critical role these platforms play in modern clinical research, emphasizing their impact on data integrity and trial efficiency.

Download the available infographic to discover how collecting ePRO & eObsRO data via interview mode can be recommended in specific circumstances.

Recently released FDA guidance showcases why electronic patient-reported outcomes (ePROs) are ideal for capturing the “voice” of the patient. See how ePRO eases oncology trials.